Higher protein expression FOXM1 was found in HCC patients with younger age (≥ 60 v.s. < 60) and poorer tumor status (T2 v.s. T3, T1 v.s. T2, and Stage I v.s. Stage III). This evidence concerns the gene FOXM1 and hepatocellular carcinoma.